Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast Cancers.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast Cancers.
Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast Cancers. Clin Cancer Res. 2021 01 15; 27(2):585-597.
View in:
PubMed
subject areas
Animals
Animals
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Hormonal
Breast Neoplasms
Breast Neoplasms
Cell Line, Tumor
Cell Line, Tumor
Cohort Studies
Cohort Studies
Disease-Free Survival
Disease-Free Survival
Female
Female
Hormone Replacement Therapy
Hormone Replacement Therapy
Humans
Humans
Kaplan-Meier Estimate
Kaplan-Meier Estimate
MCF-7 Cells
MCF-7 Cells
Mice, Inbred NOD
Mice, Inbred NOD
Mice, Knockout
Mice, Knockout
Mice, SCID
Mice, SCID
Receptors, Estrogen
Receptors, Estrogen
Tamoxifen
Tamoxifen
Thyroid Hormones
Thyroid Hormones
Transcriptome
Transcriptome
Up-Regulation
Up-Regulation
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
Elizabeth A Wellberg